NPPB and cardiac hypertrophy: While treatment of these cells with Ang II induced an obvious increase in ANP, BNP, and β-MHC levels (Figures 2(c)–2(e)), the levels of these hypertrophic markers have also been found to be increased in the hearts of patients with myocardial hypertrophy [28, 29].